Landmark review sets new clinical benchmark

• For Preventing, Managing Lead Perforation in Cardiac Implantable Devices

By Damilola Fatunmise

As cardiac implantable electronic devices (CIEDs) become increasingly prevalent worldwide, a team of cardiovascular specialists led by Dr. Olayiwola Akeem Bolaji of the Johns Hopkins Hospital Division of Cardiology has published a comprehensive review addressing one of the most feared complications in cardiac electrophysiology: lead perforation.

The review, titled “Lead Perforation in Cardiac Implantable Electronic Devices: Incidence, Diagnosis, and Management,” appears in Pacing and Clinical Electrophysiology (PACE), the official journal of the Heart Rhythm Society. Co-authored with Dr. Favour E. Markson of Jefferson Health-Einstein Hospital, Dr. Kevin F. Kwaku of Dartmouth-Hitchcock Medical Center, and Dr. Robert D. Schaller of the Hospital of the University of Pennsylvania, the publication represents a multi-institutional effort to synthesize decades of clinical evidence and provide actionable guidance for electrophysiologists and cardiac care teams.

The implantation of pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy devices has increased substantially in recent decades, driven by an aging population, improved diagnostic capabilities, and expanding indications for device therapy. According to estimates, over one million CIEDs are implanted annually in the United States alone.

While these devices have transformed the management of bradyarrhythmias, tachyarrhythmias, and heart failure, the electrodes that connect them to the heart carry inherent risks. Lead perforation—where the electrode penetrates beyond the cardiac wall into the pericardial space, thoracic cavity, or adjacent structures—occurs in approximately 0.1% to 1% of implantations, according to published literature. Though relatively infrequent, the consequences can be severe, including pericardial effusion, cardiac tamponade, hemothorax, and in some cases, death.

A meta-analysis of over 60,000 pacemaker recipients reported a mean perforation incidence of 0.82%, while a landmark study from the ICD Registry found that cardiac perforation occurred in 0.14% of first-time ICD recipients. What makes this complication particularly challenging is its variable presentation: some perforations are clinically silent and discovered incidentally on imaging, while others present as life-threatening emergencies requiring immediate intervention.

The review by Dr. Bolaji and colleagues synthesizes the evidence on patient-related and procedural risk factors that predispose individuals to lead perforation. The analysis identifies several populations at heightened risk, including elderly patients, women, and those with comorbidities such as structural heart disease, hypertension, or reduced myocardial thickness.

Anatomical considerations also play a critical role. The right ventricular apex—the most common site for lead placement—is also the thinnest portion of the ventricular wall and the most vulnerable to perforation. The review emphasizes that device type, lead design (active versus passive fixation), and operator technique significantly influence perforation likelihood.

This risk stratification framework enables clinicians to implement preventive measures through individualized procedural planning—a key element of the precision medicine approach that Dr. Bolaji advocates. Pre-procedural evaluation incorporating detailed cardiac imaging to assess myocardial thickness and anatomy, combined with appropriate lead selection, can substantially reduce both immediate and delayed perforation events.

A central theme of the review is the critical importance of timely and accurate diagnosis. Lead perforation can present with a spectrum of clinical manifestations—from subtle symptoms such as intermittent chest pain and dyspnea to dramatic presentations including hypotension, cardiac tamponade, and device malfunction. The variability in presentation makes structured diagnostic protocols essential.

The authors advocate for a multimodal diagnostic approach combining careful clinical assessment with advanced imaging. Transthoracic and transesophageal echocardiography can identify pericardial effusion and assess lead position. Computed tomography (CT), particularly ECG-gated cardiac CT with multiplanar reconstruction, offers definitive visualization of lead position relative to the myocardium and is considered the gold standard for diagnosing perforation. Fluoroscopy and device interrogation provide complementary information about lead function and electrical parameters.

Early detection is paramount: identifying perforation before progression to hemodynamic compromise enables timely intervention, reduces hospitalization duration, and improves patient outcomes. The review underscores that even asymptomatic perforations detected on imaging require careful assessment, as clinical deterioration can occur unpredictably.
The management strategies outlined in the review are tailored to perforation severity, timing, and patient clinical status. For minor, asymptomatic perforations discovered incidentally and demonstrating stable device function, conservative management with close monitoring may be appropriate. Studies have shown that many subclinical perforations remain stable without intervention.

Symptomatic or hemodynamically significant perforations, however, require active management. Percutaneous lead extraction—performed by simple traction in many cases—has become the primary intervention for most perforation scenarios. Contemporary data from UK tertiary centers demonstrates procedural success rates exceeding 98% with percutaneous approaches, avoiding the morbidity associated with open surgical extraction in most patients.

When percutaneous approaches are insufficient, or when complications such as uncontrolled pericardial hemorrhage occur, surgical intervention becomes necessary. The review emphasizes that such procedures should ideally be performed in hybrid operating rooms or cardiac catheterization laboratories with surgical backup immediately available.

A critical element throughout is multidisciplinary collaboration. The authors stress that optimal outcomes require coordination among cardiac electrophysiologists, cardiothoracic surgeons, cardiac imaging specialists, and critical care teams. Post-intervention monitoring and systematic follow-up are also essential to minimize recurrence and ensure restoration of optimal device function.

Dr. Bolaji’s review provides healthcare systems with an actionable framework for addressing lead perforation at multiple levels. At the procedural level, the findings support adherence to standardized implantation techniques, appropriate lead selection, and consideration of alternative pacing sites—such as the interventricular septum—that may reduce perforation risk.

At the institutional level, the review advocates for established protocols for complication recognition and response, ensuring that even rare events are managed with evidence-based approaches. Training and professional development for operators, particularly regarding management of complications, is identified as a key element of quality assurance.

The publication also has implications for patient counseling. As CIEDs are offered to an increasingly diverse patient population, including individuals with multiple comorbidities, informed consent discussions should include perforation as a potential complication, its symptoms, and the importance of prompt medical evaluation if concerning symptoms develop.